Skip to Main Content

In an unexpected twist, Novartis has gotten caught up in the messy investigation into Michael Cohen, President Trump’s personal attorney.

The drug maker confirmed it entered into a previously undisclosed agreement last year with Essential Consultants, which is reportedly a shell company that Cohen used to make payments for various matters.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.